LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Inicio・Lista de Acciones・Essa Pharma Inc

Essa Pharma Inc

Cerrado

1.71 1.79

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.68

Máximo

1.71

Métricas clave
By Trading Economics
Ingresos	2.2M -6.4M
BPA	-0.195
Empleados	35
EBITDA	-2.2M -8.5M

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	-1.3M 75M
Apertura anterior	-0.08
Cierre anterior	1.71

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

1.7 / 1.72 Soporte y Resistencia

Essa Pharma Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

16 may 2025, 19:39 UTC

Principales Movimientos del Mercado

UroGen Falls to 52-Week Low, FDA Document Indicates Cancer Drug Study Disagreement

16 may 2025, 23:18 UTC

Principales Noticias

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

16 may 2025, 22:30 UTC

Principales Noticias

U.S. Loses Last Triple-A Credit Rating -- Update

16 may 2025, 21:56 UTC

Charlas de Mercado

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

16 may 2025, 21:56 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

16 may 2025, 21:54 UTC

Principales Noticias

U.S. Loses Last Triple-A Credit Rating -- WSJ

16 may 2025, 21:22 UTC

Charlas de Mercado

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

16 may 2025, 21:17 UTC

Charlas de Mercado

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

16 may 2025, 21:17 UTC

Principales Noticias

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

16 may 2025, 21:05 UTC

Charlas de Mercado

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

16 may 2025, 20:55 UTC

Adquisiciones, fusiones, absorciones

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16 may 2025, 20:50 UTC

Charlas de Mercado

Ganancias

Financial Services Roundup: Market Talk

16 may 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

16 may 2025, 20:37 UTC

Principales Noticias

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

16 may 2025, 20:33 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

16 may 2025, 20:30 UTC

Adquisiciones, fusiones, absorciones

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

16 may 2025, 20:18 UTC

Principales Noticias

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

16 may 2025, 20:16 UTC

Principales Noticias

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

16 may 2025, 20:15 UTC

Ganancias

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

16 may 2025, 20:11 UTC

Adquisiciones, fusiones, absorciones

Henry Schein: William K. Daniel Joins Board

16 may 2025, 20:10 UTC

Adquisiciones, fusiones, absorciones

Henry Schein: Strategic Investment by KKR Completed

16 may 2025, 20:05 UTC

Adquisiciones, fusiones, absorciones

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16 may 2025, 19:38 UTC

Charlas de Mercado

Oil Futures Post Second Straight Weekly Gain -- Market Talk

16 may 2025, 19:07 UTC

Charlas de Mercado

U.S. Natural Gas Futures End Week Lower -- Market Talk

16 may 2025, 18:51 UTC

Principales Noticias

Early Read on Consumer Sentiment Falls to Second Lowest on Record -- 5th Update

16 may 2025, 18:41 UTC

Adquisiciones, fusiones, absorciones

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16 may 2025, 18:37 UTC

Charlas de Mercado

Gold Futures End Week on Negative Note -- Market Talk

16 may 2025, 18:35 UTC

Principales Noticias

Ozempic Drugmaker's CEO Pushed Out Amid Weight-Loss Market Challenges -- 3rd Update

16 may 2025, 18:32 UTC

Principales Noticias

Trump Floats Plan to Impose New Tariff Rates; Stocks Hold Steady -- WSJ

16 may 2025, 18:28 UTC

Charlas de Mercado

Weaker Dollar Seen as Helping Some Business to Avoid Price Increases -- Market Talk

Comparación entre iguales

Cambio de precio

Essa Pharma Inc Esperado

Consenso

By TipRanks

0 ratings

Comprar

Mantener

Vender

De acuerdo con 0 analistas que ofrecen calificaciones bursátiles a para Essa Pharma Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

1.7 / 1.72Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Essa Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.